Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer - Wikidata - wikimedia - TriplyDB

Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer

Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer

http://www.wikidata.org/entity/Q34752800

about

Prevention and treatment of bone fragility in cancer patient Lipophilic bisphosphonates plus rapamycin: a deadly combination for KRAS-mutated lung adenocarcinoma Polyoxomolybdate Bisphosphonate Heterometallic Complexes: Synthesis, Structure, and Activity on a Breast Cancer Cell Line.BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancer-initiating cells.Bisphosphonates inactivate human EGFRs to exert antitumor actions.Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma.Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory.Bisphosphonate use and the risk of endometrial cancer: a meta-analysis of observational studies.Bisphosphonates as potential adjuvants for patients with cancers of the digestive system.Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.Targeting Cancer Cells with a Bisphosphonate Prodrug.Zoledronic acid boosts γδ T-cell activity in children receiving αβ+ T and CD19+ cell-depleted grafts from an HLA-haplo-identical donor.Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways.Oral bisphosphonate use and lung cancer incidence among postmenopausal women.

P2860

Q26775765-3EB6D309-1578-4DB9-885C-A3C5D0FFDF5B Q28606634-085A8A24-AAF6-4914-BBA5-C2554E340D8F Q30971976-042196E7-9980-4B75-A45C-28BD608987A9 Q33798713-50E47EF5-E7A3-43F8-B322-D379D28B9AE9 Q34752876-0CD4E6F7-FC12-42FB-89F9-D2558B8C2EEF Q35043887-118FB8A3-9B56-4AA7-B1AF-2EB86125870B Q35828688-3DDE9D9A-7796-4676-8670-14EB1E641DFE Q35906092-B2C27427-4E87-4491-A76A-ABBEA9BC99C4 Q36097627-0D1F6130-EFAA-42A8-A9D3-AAB4A1977644 Q36471673-08E0E8A5-F7A0-436B-BA98-A98942B594E9 Q36772192-5135B01F-8458-4672-9C17-82E276C687A8 Q37694808-9B27C690-BDEF-413E-AD26-30D9B6054DA5 Q38431717-235789F9-7263-490D-9D6E-63307AD4B2F3 Q38736342-5D63E8B6-C9BC-4E0A-A07C-261D937C9C22 Q38875042-3199CB43-3BE4-4298-A521-7DD810217927 Q39138688-01B2B6CA-8211-48E2-9962-C2B66DD38D25 Q42178728-5D94564D-77D1-40FB-9A13-45909B58F74D Q46416599-445613B3-FB93-4EBA-BD48-E44508896396 Q48059346-4308698D-C289-4A28-9E05-9189CD69B2D9 Q48148231-E028A383-2DD7-4FCC-AC76-E64C9688BBDF Q54978574-F0B486A9-01A5-4D5A-8F51-296AB8F353F6 Q55237144-5E578D1A-33FF-44B0-A7E7-AD318F876CA1

P2860

Repurposing of bisphosphonates for the prevention and therapy of nonsmall cell lung and breast cancer

http://www.wikidata.org/entity/Q34752800

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@ast

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@en

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@nl

type

label

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@ast

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@en

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@nl

prefLabel

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@ast

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@en

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@nl

P1433

Q34752800-F9743E0F-7406-45BA-989D-72BA41C8F891

P1476

Q34752800-DC3D5937-F9F9-4E6D-BBBD-B778CE0DF68B

P2093

Q34752800-06234610-30BB-4F2B-B8D1-4E474BABD13E

Q34752800-0C61FD7C-7016-4912-B91D-EDF9AFDA98A9

Q34752800-124DC260-73A1-4D53-99BF-4283573B396B

Q34752800-1D19AE69-15DD-44C9-9742-3C6BF6B61098

Q34752800-1DC3A357-DA64-4F49-A1BA-389EFF20264D

Q34752800-1F80190A-37E6-4D98-968C-BDEA1661B9B5

Q34752800-2084D01F-A5DB-41C2-A221-0922CC9EA278

Q34752800-557CCB5E-6715-4B9C-BEE9-7ED07BC8F938

Q34752800-6B4FEA58-1A13-44D6-B9D0-854D88305D0C

Q34752800-6C067623-6B91-459D-A281-B5DDD8EF4ADE

P2860

Q34752800-030C5064-8B95-4D4B-9A58-8728CA70CCFF

Q34752800-06471A7B-5095-4E8A-9375-FB99DC05C50A

Q34752800-0D57F71A-AB57-47CD-BA0A-3F453DFDA7D6

Q34752800-13C724F4-D198-4187-9568-B5BD8241FBF2

Q34752800-17ABF0A9-3696-4CAA-AD23-D1BC71D96C2C

Q34752800-3440CD88-76A1-4761-B170-026B15F34EE7

Q34752800-50290EDF-DD11-4702-BED6-42DD70B5CA15

Q34752800-59F5D2E9-615C-456D-B2B7-21A0F0BE3419

Q34752800-5C8B66BF-0531-4AAD-9769-8E7D716B2955

Q34752800-5E67BDBD-B1A6-41E0-A89D-D68C6D804FCF

P304

Q34752800-DFAFDEDD-CD35-4571-AFC6-1D7E34670263

P31

Q34752800-57E5A535-6348-4EEB-873F-998A50A2A800

P356

Q34752800-511F42E4-83D5-44D0-80AD-8C114E2550EF

P407

Q34752800-0535C0A1-7508-47B6-9CFD-A8250C07B4A6

P433

Q34752800-1B6273CE-C7DF-462F-9AD0-0A28E27B34A6

P478

Q34752800-303A7A75-3F5E-4EFF-B4E8-E5109A093D3E

P50

Q34752800-42C2118C-A3B1-4467-978D-3B81CBA1B907

Q34752800-6A802F8A-15FB-4A88-8E20-C29FB50B6A2E

Q34752800-8545270A-2AA7-4911-9F91-C824851C4785

Q34752800-86C4CCC6-6947-44A5-B451-0978D7926C11

Q34752800-A478CF51-83BA-44BE-A48C-07FCF142A09D

P577

Q34752800-B1F39431-ECA4-4703-8E6C-4CD52BF2176C

P5875

Q34752800-EBD2BA9C-2CE9-4376-89B8-90AA5EF73BE6

P698

Q34752800-9871150A-0364-4AC9-9FC1-5680D6B3B288

P932

Q34752800-385C597D-2860-47CA-96A4-BE0D0D5EBDAB

P356

PNAS.1421422111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Repurposing of bisphosphonates ...... ll cell lung and breast cancer

@en

P2093

Agnes Stachnik

http://www.w3.org/2001/XMLSchema#string

Alberta Zallone

http://www.w3.org/2001/XMLSchema#string

Aneel K Aggarwal

http://www.w3.org/2001/XMLSchema#string

Christoph Buettner

http://www.w3.org/2001/XMLSchema#string

Jameel Iqbal

http://www.w3.org/2001/XMLSchema#string

Jaya Sangodkar

http://www.w3.org/2001/XMLSchema#string

Jianhua Li

http://www.w3.org/2001/XMLSchema#string

Li Sun

http://www.w3.org/2001/XMLSchema#string

Ling-Ling Zhu

http://www.w3.org/2001/XMLSchema#string

Maria I New

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic mutations affect key pathways in lung adenocarcinoma

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Treml4, an Ig superfamily member, mediates presentation of several antigens to T cells in vivo, including protective immunity to HER2 protein

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

EGFR antagonists in cancer treatment

Bisphosphonates: the first 40 years.

EGFR Signaling in Colorectal Carcinoma.

Bisphosphonates inactivate human EGFRs to exert antitumor actions.

Use of bisphosphonates and reduced risk of colorectal cancer.

P304

17995-18000

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1421422111

http://www.w3.org/2001/XMLSchema#string

P407

P433

50

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Graziana Colaianni

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269166176

http://www.w3.org/2001/XMLSchema#string

P698

25453078

http://www.w3.org/2001/XMLSchema#string

P932

4273392

http://www.w3.org/2001/XMLSchema#string